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Edited by Giulio Superti-FurgaAbstract Proline-rich tyrosine kinase2 (Pyk2) is a cytoplasmic
tyrosine kinase related to focal adhesion kinase. Pyk2 expression
has been known to be restricted to neuronal and hematopoietic
cells and Pyk2 tyrosine phosphorylation and its kinase activity
is important for the function of monocytes/macrophages. In
NB4 acute promyelocytic leukemia cells, the expression of
Pyk2 was increased in parallel with diﬀerentiation, and inhibited
by PD98059, indicating Pyk2 expression is regulated through
MAPK/ERK pathway. Dominant-negative kinase-deﬁcient mu-
tant of Pyk2 reduced the diﬀerentiation of NB4 cells in response
to phorbol 12-mystate 13-acetate. Transcription factor CCAAT
enhancer-binding protein (C/EBP) b was required to induce
Pyk2 expression in promoter analysis. These results suggest that
Pyk2 is induced and involved in monocyte diﬀerentiation and C/
EBPb is a critical regulator of the Pyk2 expression.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Monocytes and macrophages are cells that serve critical
functions in immune defense system, including the phagocyto-
sis of microbial pathogens, the proteolytic processing and pre-
sentation of foreign antigens, and the elaboration of a
repertoire of cytokines. Circulating monocytes are released
from the bone marrow and circulate in the blood for 1–3 days.
Following recruitment to tissues, they can diﬀerentiate into
macrophages, as has been shown in vitro [1]. These processes
of cell formation are called monopoiesis. During monopoiesis,
monocytes/macrophages undergo several phenotypic changes,
such as lamellipodia protrusion, ruﬄe formation, adhesion,
and spreading. Monocyte adhesion to endothelial cells is an
essential prerequisite for transmigration leading to theirAbbreviations: Pyk2, proline-rich tyrosine kinase2; FAK, focal adhe-
sion kinase; PMA, phorbol 12-mystate 13-acetate; C/EBPb, CCAAT
enhancer-binding protein b; FN, ﬁbronectin; MEK/ERK, MAPK/
ERK kinase/extracellular signal-regulated kinases; NBT, nitroblue
tetrazolium; ChIP, chromatin immunoprecipitation
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macrophages [2]. The mechanism of formation of adhesion
contacts in macrophages, known as podosomes, is not well
understood since monocyte/macrophages do not express focal
adhesion kinase (FAK) [3].
Proline-rich tyrosine kinase 2 (Pyk2), also known as related
adhesion focal tyrosine kinase (RAFTK) or cell adhesion
kinase (CAK), is a cytoplasmic tyrosine kinase related to
FAK [4]. Pyk2 shows considerable sequence homology and
structural similarity to FAK, including consensus motifs in
the catalytic domain. Unlike FAK, Pyk2 expression is rela-
tively restricted. Pyk2 is predominantly expressed in the central
nervous system and in cells and tissues derived from hemato-
poietic lineages. In neuronal cells, Pyk2 links various extracel-
lular stimuli that lead to elevation of intracellular calcium
concentration, such as activation of the G-protein-coupled
receptors, membrane depolarization, with ion channel and
mitogen-activated protein kinase functions [5,6]. It has also
been demonstrated that Pyk2 plays a role in signaling by lym-
phocyte antigen receptors, integrin receptors, and chemokine
receptors in hematopoietic cells [7,8]. Recently, Pyk2 has been
shown to play a role in macrophage morphology and migra-
tion in response to lipopolysaccharide and chemokines [9,10].
So it is possible that Pyk2 participates in diﬀerentiation of
monocytes/macrophages and the level of Pyk2 is regulated
during this process. However, little is known about the role
of Pyk2 in monocyte diﬀerentiation and the regulation of
Pyk2 gene expression as yet.
Several transcription factors are known to be involved in
monocyte diﬀerentiation. The CCAAT enhancer-binding
protein (C/EBP) represents a family of transcription factors
which has been suggested to play a role in monocyte diﬀer-
entiation [11]. C/EBP is a family of basic region-leucine zip-
per (bZIP) protein and has C/EBPa, b, c, d, e, and f
isoforms. These proteins dimerize through their leucine zip-
per domains and bind to DNA through their adjacent basic
regions. C/EBPa,C/EBPb, C/EBPd, or C/EBPe can induce
granulocytic diﬀerentiation in myeloblastic cell lines [12],
and C/EBPa, C/EBPb, or C/EBPd reported to induce mono-
cytic genes in P388 lymphoblasts [13]. C/EBPb, in particular,
has been shown to be induced upon monocyte diﬀerentiation
[14,15] and to be a potent activator in the induction of acute
phase and inﬂammatory genes responsive to LPS, IL-1, or
IL-6 [16]. C/EBPb-deﬁcient mice are viable but show defects
in innate immunity that result from impaired bactericidal
activity of macrophages [17].
In this study, we investigated whether Pyk2 is induced and
involved in monocyte diﬀerentiation. And we also examinedblished by Elsevier B.V. All rights reserved.
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ﬁrst report clarifying Pyk2 is involved in phorbol 12-mystate
13-acetate (PMA)-induced monocytic diﬀerentiation.2. Materials and methods
2.1. Cell culture, diﬀerentiation and nitroblue tetrazolium (NBT)
reduction assay
Human promyelocytic cell line NB4 (gifted from Dr. Hyung Hoi
Kim, Pusan National University) were maintained in RPMI 1640 med-
ium supplemented with 1% penicillin–streptomycin (PS), and 10%
heat-inactivated fetal bovine serum (FBS; Gibco BRL). Human cervi-
cal carcinoma HeLa cells were maintained in Dulbeccos modiﬁed Ea-
gles medium (DMEM) supplemented with 1% PS, and 10% FBS. They
were maintained in a 37 C, 5% CO2, fully humidiﬁed incubator, and
prepared for experimental procedures when they were in log-phase
growth.
To induce monocytic diﬀerentiation, NB4 cells were incubated with
20 nM PMA (Sigma, St. Louis, MO) for up to 72 h. The morpholog-
ical change of NB4 cells to the monocyte/macrophage phenotype was
easily detected with inverted microscopy (ZEIZZ). After the treatment
of PMA, cells were harvested, and resuspended in PBS containing
2 mg/ml of NBT (Amnesco) and 20 ng/ml of PMA. After incubated
at 37 C for 1 h, incubation was stopped by the addition of cold 2 M
HCl. The formazan product was obtained by centrifugation of the
sample at 700 · g for 10 min. The supernatant was discarded, and
the formazan was dissolved in DMSO. The absorbance was measured
at 595 nm.
2.2. Flow cytometry
The expression of the myeloid-monocyte speciﬁc antigen CD14 on
NB4 cell surface was determined by direct immunoﬂuorescent staining
with FITC-conjugated mouse monoclonal antibodies against human
CD14 (Beckman-Coulter). FITC-conjugated mouse IgG2a was used
as the negative control. The cells were harvested and then suspended
in PBS. The FITC-conjugated CD14 or IgG2a antibody was added
to cells at room temperature for 30 min, protected from light. Cells
were washed with PBS and assayed by ﬂow cytometry (Beckman-Coul-
ter).
2.3. Western blot analysis
Equal amount of whole cell extract was separated by SDS/PAGE
(10% gel) and transferred PVDF membranes (Millipore, Dedford,
MA). The membranes were incubated with anti-Pyk2, anti-myc, anti-
b-tubulin, anti-C/EBPb (Santa Cruz Biotechnology, CA), or anti-phos-
pho-Pyk2 (Cell Signaling Technology Inc., MA) and then peroxidase
conjugated secondary antibody. The protein bands were detected by
the enhanced chemiluminescence detection system according to the
recommended procedure (Amersham Co, Arlingtion Height, IL).
2.4. RNA isolation and reverse transcription polymerase chain reaction
(RT-PCR)
Total RNA was isolated from cells using Trizol reagent (Invitrogen)
according to the manufacturers instruction. The cDNA was synthe-
sized from 2 lg of total RNA using AMV-RTase (Promega, Mann-
heim, Germany) at 42 C for 1 h. The synthesized cDNA was
ampliﬁed using Pyk2 and b-actin primers with DYAD thermocycler
(MJ Research, Watertown, MA, USA). PCR primers for Pyk2 were
5 0-CAAATGCACTGTCCAGACG-3 0 (sense) and 5 0-TGGGCTTTA-
AGTTCTCCTGC-3 0 (antisense); for b-actin were 5 0-GACTACCTC-
ATGAAGATC-3 0 (sense) and 5 0-GATCCACATCTGCTGGAA-30
(antisense). PCR reactions were cycled as follows: initial denaturation
at 95 C for 2 min and then 30 cycles for Pyk2 and b-actin at 95 C for
20 s, 56 C for 40 s, and 72 C for 30 s. PCR products were examined
by electrophoresis on a 1% agarose gel.
2.5. Cloning of the Pyk2 promoter region
Pyk2 promoter region was ampliﬁed by nested-PCR using genomic
DNA of human spleen (BioChain, Hayward, CA) as a template. Pri-
mary PCR primers were 5 0-TTAAGACTCCACACCCCTGG-30
(sense) and 5 0-ATCCCATCACAAACTCCCC-3 0 (antisense). ThePCR product was nested ampliﬁed with sense primer containing the
KpnI restriction site (5 0-CCCGGTACCTACTGACAGCATCCTTA-
CATTCC-3 0) and antisense primer containing the SacI restriction
site (5 0-CCCGAGCTCAAGTAGGTTTCCAGTAACACGG-3 0).
The ampliﬁed DNA fragment 2063/+113 was cloned into the
pGL3-Basic luciferase reporter vector (Promega) at KpnI/SacI site
(pGL3B/Pyk2-2063). Using this pGL3B/Pyk2-2063 as a template, seri-
al 5 0 end deletion constructs were ampliﬁed by PCR with the same
antisense primer and sense primers containing the KpnI site:
Pyk2-1681-sense (5 0-CCCGGTACCAACATGGTGAAACCCTGCC-
3 0),
Pyk2-1286-sense (5 0-CCCGGTACCTTCTCCATGTTAGTTTTGC-
CCTG-3 0),
Pyk2-479-sense (5 0-CCCGGTACCTTCTCCACCAGGTTGTTGAG-
G-3 0),
Pyk2-321-sense (5 0- CCCGGTACCGTAGCAGACGGCGCAGAG-
CAAC-3 0).
2.6. Transient transfection and luciferase assay
HeLa cells were transfected with plasmids using Polyfect reagent
(Qiagen, Valencia, CA) according to the manufacturers instruction.
pSV110-b-galactosidase control plasmid was cotransfected as an inter-
nal control for transfection eﬃciency. After 48 h of transfection, cells
were lysed in the cell culture lysis buﬀer (Promega). Luciferase activi-
ties were measured with the luciferase assay substrate (Promega) using
Victor 3 luminometer (Perkin–Elmer, Rockville, MD). Transfection
eﬃciency was corrected by b-galactosidase activity. All transfection re-
sults represent the mean of three independent experiments.
2.7. Chromatin immunoprecipitation (ChIP) assay
NB4 cells were collected and cross-linked with 1% formaldehyde at
37 C for 10 min, then were rinsed with ice-cold phosphate-buﬀered
saline twice. Cells were then resuspended in lysis buﬀer (1% SDS,
10 mM EDTA, 50 mM Tris–Cl, pH 8.1, 1 mM PMSF, protease inhib-
itor cocktail (Roche)) and sonicated nine times for 10 s followed by
centrifugation for 10 min. Supernatants were collected and diluted in
buﬀer (1.1% Triton X-100, 0.01% SDS, 1.2 mM EDTA, 167 mM
NaCl, 16.7 mM Tris–HCl, pH 8.1) followed by immunoclearing with
protein A-agarose and sheared salmon sperm DNA for 30 min at
4 C. Immunoprecipitation was performed overnight at 4 C with the
C/EBPb antibody (Santa Cruz Biotechnology). After immunoprecipi-
tation, protein A-agarose with sheared salmon sperm DNA was added
and the incubation was continued for another hour. Precipitates were
washed sequentially in the following three diﬀerent washing buﬀers for
5 min each; a low salt washing buﬀer (0.1% SDS, 1% Triton X-100,
2 mM EDTA, 20 mM Tris–HCl, pH 8.1, 150 mM NaCl), a high salt
washing buﬀer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM
Tris–HCl, pH 8.1, 500 mM NaCl), and a LiCl washing buﬀer
(0.25 M LiCl, 1% Nonidet P-40, 1% deoxycholate, 1 mM EDTA,
10 mM Tris–HCl, pH 8.1). Immune complexes were washed twice with
Tris–EDTA buﬀer and eluted three times with 1% SDS, 0.1 M NaH-
CO3. The eluted materials were pooled and heated at 65 C for at least
6 h to reverse the formaldehyde cross-linking. DNA fragments were
puriﬁed and reserved for PCR ampliﬁcation. The primers were used
as follow: 479 sense (5 0-CCCGGTACCTTCTCCACCAGGTTGTT-
GAGG-3 0), +113 antisense (5 0-CCCGAGCTCAAGTAGGTTTC-
CAGTAACACGG-3 0).3. Results and discussion
3.1. The expression of Pyk2 is upregulated during PMA-induced
monocytic diﬀerentiation of NB4 cells
The human promyelocytic leukemia cell lines NB4 is a useful
model for the study of cellular diﬀerentiation. NB4 cells can be
diﬀerentiated toward monocytes/macrophages by PMA [18]. It
was assessed the diﬀerentiating potential of PMA in NB4 cells
using cell morphology, NBT reduction, and CD14 expression.
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Fig. 1. PMA induces the diﬀerentiation of NB4 cells. (A–C) PMA-induced morphological changes of NB4 cells. NB4 cells were incubated with PMA
(20 nM) for indicated time. Images of cells in culture at this time point were obtained using an inverted phase contrast microscope, attached to a
video camera, and captured using Axio Vision AC image software. PMA induced the aggregation and adherence of NB4 cells (arrowhead). Scale bar
is 50 lm. NB4 cells were treated with the indicated concentrations of PMA for 48 h at 37 C (D) or pretreated with 50 lM of PD98059 for 2 h at
37 C and then stimulated with 20 nM of PMA for 48 h at 37 C (E, F) and diﬀerentiation was measured by the NBT reduction assay as described in
Section 2. Results were presented as the means ± S.E. of four individual experiments performed in duplicate. *P < 0.05 and **P < 0.01 versus control
group (D) or *P < 0.05 versus PMA alone (E). Cell-surface expression of monocyte diﬀerentiation marker CD14 on NB4 cells was analysed by ﬂow
cytometry (F) as described in Section 2.
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spreading onto culture dish plates, which are the hallmarks
of monocyte diﬀerentiation (Fig. 1A–C). Some cells clustered
and a few cells attached and spread out at 24 h, and more cells
were attached and displayed the extended shape at 48 h. PMA-
treated NB4 cells revealed the increased NBT reduction in a
dose-dependent manner (Fig. 1D). Flow cytometry analysis
of the cell surface expression of the monocyte diﬀerentiation
marker CD14 conﬁrmed that NB4 cells were diﬀerentiated
by PMA (Fig. 1F).
The adhesion and migration of monocytes/macrophages
requires orderly changes in cytoskeletal structures and focal
contacts. Recent reports demonstrated that Pyk2 is involved
in F-actin organization during maturation of oocyte [19] and
regulates diﬀerentiation of keratinocytes and neuronal cells[20,21]. Moreover, Pyk2 has been reported to participate in
M-CSF signaling of monocytes/macrophages [22]. So it is pos-
sible that Pyk2 might involve in the phenotypic changes and
diﬀerentiation process. To examine whether the level of Pyk2
is changed during monocyte diﬀerentiation, NB4 cells were
treated with PMA and the expression level of Pyk2 was deter-
mined by Western blotting and RT-PCR. PMA increased the
protein and mRNA level of Pyk2 in dose- and time-dependent
manners (Fig. 2A–D) and the increased expression of Pyk2
was paralleled with the extent of diﬀerentiation (Fig. 1A–D).
These results suggest that Pyk2 expression is upregulated dur-
ing PMA-induced monocytic diﬀerentiation.
PMA-initiated signals have been known to activate the
MAPK cascade including MAPK/ERK kinase/extracellular
signal-regulated kinases (MEK/ERK) [23]. To gain insight into
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Fig. 2. The expression of Pyk2 was induced by PMA during monocyte diﬀerentiation. (A, B) NB4 cells were treated with PMA and equal whole cell
lysates were analyzed by immunoblot with anti-Pyk2 antibody. Western blot detection of b-tubulin was estimated protein-loading control for each
lane. (C, D) NB4 cells were treated with PMA and RT-PCR was performed using Pyk2- or b-actin-speciﬁc primers, as described in Section 2. The b-
actin gene expression was analyzed to control for mRNA integrity and loading. (E, F) NB4 cells were pretreated with indicated concentration of
PD98059 or 20 lM of SB203580 (SB) and then stimulated with PMA. Western blotting (E) and RT-PCR (F) were performed as described above. (G)
NB4 cells were seeded in FN-coated or non-coated plastic culture dishes and treated with PMA. Equal whole cell lysates were analyzed by
immunoblot with anti-Pyk2 antibody.
418 M.H. Park et al. / FEBS Letters 582 (2008) 415–422the pathways that regulate the Pyk2 expression in NB4 cells,
we examined the eﬀect of the MAPK inhibitor PD98059
(ERK inhibitor), and SB203580 (p38 inhibitor) on the expres-
sion of Pyk2. While SB203580 did not block the expression of
Pyk2 (Fig. 2E), PD98059 blocked the PMA-induced increase
of Pyk2 (Fig. 2E and F). In addition, PD98059 blocked the
PMA-induced increase of NBT reduction (Fig. 1E) and cell
surface CD14 expression (Fig. 1F). These data suggest that
the MEK-ERK cascade is involved in the expression of Pyk2
during PMA-induced monocytic diﬀerentiation.
Since ﬁbronectin has been recognized as the key element in
promoting cell adhesion and various functions of monocyte
[24], we examined the eﬀect of ﬁbronectin (FN) on the expres-
sion of Pyk2 during PMA-induced monocytic diﬀerentiation.
NB4 cells were seeded onto FN-coated or non-coated plastic
culture dishes and treated with PMA. FN alone did not in-
duce adhesion and morphological change, and costimulation
of FN and PMA had similar eﬀect on diﬀerentiation of
NB4 cells to PMA alone (data not shown). As shown in
Fig. 2G, FN alone did not induce Pyk2 and PMA-induced
expression of Pyk2 was not aﬀected by the presence of FN.
These results indicate that the induction of Pyk2 by PMA is
not dependent on FN.3.2. Kinase-deﬁcient mutant of Pyk2 suppresses the monocytic
diﬀerentiation of NB4 cells
In order to verify that Pyk2 is involved in monocyte diﬀeren-
tiation, NB4 cells were transfected with myc-tagged wild-type
(WT) Pyk2 plasmid or myc-tagged kinase-deﬁcient (KD)
K457A-Pyk2 plasmid, containing a lysine (K) to alanine (A)
mutation in the ATP-binding site of catalytic domain and then
treated with PMA for monocyte diﬀerentiation. After 30 h,
cell-surface expression of monocyte diﬀerentiation marker
CD14 on NB4 cells was analyzed by ﬂow cytometry. While
cells transfected with WT-Pyk2 expressed slightly more
CD14 on their surface in response to PMA, CD14 expression
by PMA was signiﬁcantly reduced in cells transfected with
KD-Pyk2 (Fig. 3). This result provides direct evidence that
Pyk2 expression plays an important role in monocyte diﬀeren-
tiation. To assess the impact of PMA and KD-Pyk2, the level
of phospho-Pyk2 (as an indicator of Pyk2 activation) was
monitored in plasmid-transfected cells in the absence or pres-
ence of PMA (Fig. 3E). WT-Pyk2 or KD-Pyk2 plasmids were
expressed in similar extent, while the expression of transfected
plasmids was slightly upregulated by PMA (anti-myc in middle
panel). PMA induced the phosphorylation of Pyk2 in mock or
WT-Pyk2 transfected cells but it failed to phosphorylate
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KD-Pyk2 acts as a dominant-negative mutant.
As NB4 cells diﬀerentiate into monocytes, morphological
changes such as adhesion and spreading are accompanied,
which requires cytoskeleton rearrangement. Pyk2 is present
at lamellipodia of monocytes [25] and studies of cells derived
from Pyk2-deﬁcient mice indicate that Pyk2 is important for
the contractile activity of lamellipodia in migrating macro-
phages [10]. And Pyk2 has been reported to be involved in
FccR-mediated phagocytosis [26]. So Pyk2 might be required
in diﬀerentiation of NB4 cells and increased Pyk2 could play
an important role in spreading and motility as well as mono-
cyte/macrophage functions such as phagocytosis.3.3. C/EBPb regulates the transactivation of Pyk2 promoter
To further understand the mechanism of Pyk2 expression at
the level of gene transcription, we cloned and studied the pro-
moter region of Pyk2 gene. Database analysis of the 5 0-ﬂanking
region for known consensus sequences in Pyk2 promoter indi-
cates the presence of binding sites for C/EBPb. In order to elu-
cidate whether C/EBPb increases Pyk2 expression, HeLa cells
were transfected with the indicated amounts of the expression
vectors encoding C/EBPb along with the human Pyk2 pro-
moter luciferase reporter (Pyk2-2063-Luc). The results shown
in Fig. 4A showed that C/EBPb signiﬁcantly increased the
transactivation of Pyk2 promoter. Since it has been known that
a naturally occurring isoform of C/EBPb, LIP (liver-enriched
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420 M.H. Park et al. / FEBS Letters 582 (2008) 415–422inhibitory protein), exhibits a dominant-negative eﬀect on a C/
EBPb-dependent promoter-reporter due to a lack of the trans-
activation domain [27], the eﬀect of expression vectors encoding
LIP was examined through cotransfection with C/EBPb-
expression vectors. LIP overexpression inhibited C/EBPb-
induced transactivation of the Pyk2 promoter activity
(Fig. 4B). These data indicate that C/EBPb activates the Pyk2
promoter and the transactivation domain of C/EBPb is essen-
tial for its activation of the Pyk2 promoter.
Next, we identiﬁed the C/EBPb responsive region of Pyk2
promoter. It was found that there are six potential C/EBPb
binding sites within 2.063 kb Pyk2 promoter from databasesearch (MOTIF Search, Fig. 4C). To identify the promoter
region responsible for C/EBPb binding to Pyk2 promoter, a
series of sequential deleted construct of the Pyk2 promoter re-
gion was generated and subjected in reporter assay with
cotransfection of C/EBPb expression plasmid into HeLa cells.
As shown in Fig. 4C, the activity of Pyk2-479-Luc promoter
construct was well maintained and similar to that of other pro-
moter constructs, while Pyk2-321-Luc promoter construct (not
including putative C/EBPb binding site) was not maintained
and not induced by C/EBPb. Based on this result, Pyk2 pro-
moter region (479 to 321) including just one putative C/
EBPb binding site was regarded as a C/EBPb responsive site
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Fig. 5. PMA induces the expression of Pyk2 through MEK/ERK-
dependent upregulation of C/EBPb. (A) HeLa cells were cotransfected
with Pyk2-2063-Luc and vector expressing C/EBPb. Twenty-four
hours after transfection, cells were pretreated with 20 lM of PD98059
for 2 h at 37 C and then stimulated with 20 nM of PMA for 24 h at
37 C. Luciferase assay was performed as described in Section 2.
*,#P < 0.05 versus control (no PMA); **,## P < 0.05 versus PMA alone
(* and **, mock; # and ##, C/EBPb). (B, C) NB4 cells were treated
with PMA (B) or pretreated with indicated concentration of PD98059
and stimulated with PMA as described in Fig. 2E (C). Equal whole cell
lysates were analyzed by immunoblot with anti-C/EBPb antibody.
Western blot detection of b-tubulin was estimated protein-loading
control for each lane.
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sion.
To conﬁrm that C/EBPb could directly bind to the Pyk2
promoter in vivo and to further deﬁne the C/EBPb response
elements in the promoter, chromatin immunoprecipitation
(ChIP) assay was carried out, which detects speciﬁc genomic
DNA sequences that are associated with a particular transcrip-
tion factor in intact cells. NB4 cells were treated with 20 nM of
PMA for 48 h at 37 C. After treatment, proteins were cross-
linked to genomicDNA and immumoprecipitation with normal
mouse IgG, or polyclonal antibody to C/EBPb was performed.
And then PCRwas conducted with primers designed to amplify
a 609-bp fragment (from 479 to +113). As shown in Fig. 4D,
the binding of C/EBPb to this site of Pyk2 promoter was in-
creased by PMA-treatment. These results suggest that C/EBPb
is responsible to bind and transactivate the Pyk2 promoter.3.4. PMA induces the expression of Pyk2 through MEK/ERK-
dependent upregulation of C/EBPb
In order to elucidate whether C/EBPb increases the PMA-
induced Pyk2 expression, HeLa cells were transfected with
the expression vectors encoding C/EBPb along with the hu-
man Pyk2 promoter Pyk2-2063-Luc and treated with PMA.
As predicted, PMA provoked the transactivation of the
Pyk2 promoter in HeLa cells and C/EBPb increased PMA-in-
duced transactivation of Pyk2 promoter (Fig. 5A) indicating
that C/EBPb and PMA act cooperatively to induce transacti-
vation of the Pyk2 promoter. To verify that the expression of
C/EBPb is aﬀected by PMA in NB4 cells, NB4 cells were trea-
ted with 20 nM of PMA for the indicated times at 37 C.
PMA increased the level of total cellular C/EBPb (Fig. 5B)
and the expression of C/EBPb is paralleled with increase in
Pyk2 (Fig. 2B). Because PD98059 blocked both the transcrip-
tion and expression of Pyk2 (Fig. 2E and F), it was investi-
gated the eﬀect of PD98059 on the Pyk2 promoter activity.
PD98059 suppressed Pyk2 transactivation by C/EBPb
(Fig. 5A) and PMA-induced expression of C/EBPb
(Fig. 5C). These results suggest that C/EBPb plays a role as
an activator of the transcription of Pyk2 during PMA-in-
duced monocytic diﬀerentiation and PMA induces the expres-
sion of Pyk2 through MEK/ERK-dependent upregulation of
C/EBPb.
C/EBPa and C/EBPb have been shown to play an impor-
tant role in tissue-speciﬁc and diﬀerentiation-dependent IL-
10 transcription [14]. It has been reported that C/EBPb is a
major transcription factor in retinoic acid-induced diﬀerentia-
tion of NB4 acute promyelocytic leukemia cells [12] and is re-
quired for 1,25-dihydroxyvitamin D3-induced monocytic
diﬀerentiation of HL60 cells [15]. And C/EBP levels are low
in immature myeloid cells, increase after stimulation with
LPS, IL-6, and IL-1, and are highest in macrophages and
neutrophils [11]. Moreover, PMA, acting through the protein
kinase C pathway, has been reported to increase the site-spe-
ciﬁc phosphorylation and activity of C/EBPb [28]. Therefore,
PMA could not only induce C/EBPb level but also increase
the activity of C/EBPb through MEK/ERK pathway. These
increased and activated C/EBPb could bind to the promoter
of Pyk2 gene and provoke the expression of Pyk2, which
might force promyelocytes to diﬀerentiate into monocytes/
macrophages.
In conclusion, our study shows for the ﬁrst time that up-reg-
ulation of Pyk2 gene is functionally important for monocytic
diﬀerentiation by PMA and transcription factor C/EBPb is a
critical regulator of the Pyk2 induction. This study further sug-
gests that the transactivational activity of C/EBPb, the expres-
sion of Pyk2 gene and monocyte diﬀerentiation is regulated by
MEK/ERK signaling pathway. Our ﬁnding provides insight
into the molecular mechanism of monocytic diﬀerentiation in
promyelocytic leukemia cells.Acknowledgements: We thank Dr. Patricia A. Kruk (University of
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